5-(1H-Indol-3-yl)-N-(2-nitrophenyl)-1,3,4-oxadiazol-2-amine

ID: ALA4102399

Chembl Id: CHEMBL4102399

PubChem CID: 137659638

Max Phase: Preclinical

Molecular Formula: C16H11N5O3

Molecular Weight: 321.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])c1ccccc1Nc1nnc(-c2c[nH]c3ccccc23)o1

Standard InChI:  InChI=1S/C16H11N5O3/c22-21(23)14-8-4-3-7-13(14)18-16-20-19-15(24-16)11-9-17-12-6-2-1-5-10(11)12/h1-9,17H,(H,18,20)

Standard InChI Key:  KMBFUJJRYOMMRA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4102399

    ---

Associated Targets(Human)

BCL2 Tclin Apoptosis regulator Bcl-2 (3787 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KG-1a (249 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 321.30Molecular Weight (Monoisotopic): 321.0862AlogP: 3.87#Rotatable Bonds: 4
Polar Surface Area: 109.88Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.48CX Basic pKa: CX LogP: 4.44CX LogD: 2.85
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.44Np Likeness Score: -1.58

References

1. Hamdy R, Ziedan NI, Ali S, Bordoni C, El-Sadek M, Lashin E, Brancale A, Jones AT, Westwell AD..  (2017)  Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents.,  27  (4): [PMID:28087272] [10.1016/j.bmcl.2016.12.061]
2. Liu T, Wu Z, He Y, Xiao Y, Xia C..  (2020)  Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy.,  201  [PMID:32563811] [10.1016/j.ejmech.2020.112446]

Source